GlaxoSmithKline Czech Republic - Balance Sheet

Assets and Their Funding (CZK mil)
Pharmaceutical | Czech Republic | March 07, 2018
$10.99
Excel Sheet

GlaxoSmithKline Czech Republic's total assets reached CZK 2,107 mil at the end of 2015, up 8.14% when compared to the previous year.

Current assets amounted to CZK 2,066 mil, or 98.1% of total assets while cash reached CZK 515 mil at the end of 2015.

On the other hand, total debt reached CZK 0.000 mil at the year-end, or 98.1% of total assets while firm's equity amounted to CZK 1,338 mil. As a result, net debt reached CZK -515 mil at the end of 2015 and accounted for -38.5% of equity.

You can see all the company’s data at GlaxoSmithKline Czech Republic Profile, or you can download a report on the company in the report section.